Invesco Nasdaq Biotechnology ETF Company Overview

Invesco Nasdaq Biotechnology ETF logo
Invesco Nasdaq Biotechnology ETF
Invesco Nasdaq Biotechnology ETF primary media

About Invesco Nasdaq Biotechnology ETF

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) is a fund that focuses on the biotechnology sector, aiming to track the investment results of an index composed of biotechnology and pharmaceutical companies listed on the NASDAQ. This ETF enables investors to gain exposure to a broad range of companies involved in the research, development, and distribution of innovative medical treatments and technologies. The main objective of the fund is to replicate the performance of the NASDAQ Biotechnology Index, thereby providing investment results that closely correspond, before fees and expenses, to the performance of its underlying index. Through its investments, the Invesco Nasdaq Biotechnology ETF plays a crucial role in supporting the growth and development of the biotech industry, offering a diversified portfolio that spans various markets and stages of the biotechnology development cycle.

What is Invesco Nasdaq Biotechnology ETF known for?

Snapshot

2021
Year founded
5023
Employees
Atlanta, United States
Head office
Loading Map...

Operations

All Locations
United States

Products and/or services of Invesco Nasdaq Biotechnology ETF

  • Provides diversified exposure to biotechnology and pharmaceutical companies.
  • Offers potential for long-term capital growth through investments in Nasdaq-listed biotech firms.
  • Aims for high-risk adjusted returns by investing in innovative healthcare solutions.
  • Seeks to mirror the performance of the NASDAQ Biotechnology Index.
  • Facilitates liquidity and accessibility for investors through exchange-traded fund structure.
  • Employs professional management with expertise in biotech sector investing.

Invesco Nasdaq Biotechnology ETF executive team

    Connect with us

    Disclaimer

    Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

    Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.